358 related articles for article (PubMed ID: 18683536)
21. Immunohistochemical evaluation of STAT3-p-tyr705 expression in feline mammary gland tumours and correlation with histologic grade.
Petterino C; Ratto A; Podestà G; Drigo M; Pellegrino C
Res Vet Sci; 2007 Apr; 82(2):218-24. PubMed ID: 16934302
[TBL] [Abstract][Full Text] [Related]
22. Reduced PTEN protein expression and its prognostic implications in canine and feline mammary tumors.
Ressel L; Millanta F; Caleri E; Innocenti VM; Poli A
Vet Pathol; 2009 Sep; 46(5):860-8. PubMed ID: 19429983
[TBL] [Abstract][Full Text] [Related]
23. Versican and hyaluronan expression in canine colonic adenomas and carcinomas: relation to malignancy and depth of tumour invasion.
Mukaratirwa S; van Ederen AM; Gruys E; Nederbragt H
J Comp Pathol; 2004 Nov; 131(4):259-70. PubMed ID: 15511534
[TBL] [Abstract][Full Text] [Related]
24. Mutation and overexpression of p53 as a prognostic factor in canine mammary tumors.
Lee CH; Kim WH; Lim JH; Kang MS; Kim DY; Kweon OK
J Vet Sci; 2004 Mar; 5(1):63-9. PubMed ID: 15028887
[TBL] [Abstract][Full Text] [Related]
25. P53 protein immunohistochemical expression in colonic adenomas with and without associated carcinoma.
Saleh HA; Aburashed A; Bober P; Tabaczka P
Am J Gastroenterol; 1998 Jun; 93(6):980-4. PubMed ID: 9647033
[TBL] [Abstract][Full Text] [Related]
26. Cox-2 expression in canine mammary carcinomas: correlation with angiogenesis and overall survival.
Lavalle GE; Bertagnolli AC; Tavares WL; Cassali GD
Vet Pathol; 2009 Nov; 46(6):1275-80. PubMed ID: 19605908
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of hormone receptor expression for use in predicting survival of female dogs with malignant mammary gland tumors.
Chang CC; Tsai MH; Liao JW; Chan JP; Wong ML; Chang SC
J Am Vet Med Assoc; 2009 Aug; 235(4):391-6. PubMed ID: 19681719
[TBL] [Abstract][Full Text] [Related]
28. Increased Derlin-1 expression in metastases of canine mammary adenocarcinomas.
Klopfleisch R; Schütze M; Linzmann H; Brunnberg L; Gruber AD
J Comp Pathol; 2010 Jan; 142(1):79-83. PubMed ID: 19632687
[TBL] [Abstract][Full Text] [Related]
29. Proliferative activity, apoptosis and expression of oestrogen receptor and Bcl-2 oncoprotein in canine mammary gland tumours.
Yang WY; Liu CH; Chang CJ; Lee CC; Chang KJ; Lin CT
J Comp Pathol; 2006 Jan; 134(1):70-9. PubMed ID: 16423573
[TBL] [Abstract][Full Text] [Related]
30. Of humans and canines: Immunohistochemical analysis of PCNA, Bcl-2, p53, cytokeratin and ER in mammary tumours.
Kumaraguruparan R; Prathiba D; Nagini S
Res Vet Sci; 2006 Oct; 81(2):218-24. PubMed ID: 16740286
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical expression of Epidermal Growth Factor Receptor (EGFR) in canine mammary tissues.
Gama A; Gärtner F; Alves A; Schmitt F
Res Vet Sci; 2009 Dec; 87(3):432-7. PubMed ID: 19464036
[TBL] [Abstract][Full Text] [Related]
32. An Immunohistochemical study of HER-2 expression in feline mammary tumours.
Rasotto R; Caliari D; Castagnaro M; Zanetti R; Zappulli V
J Comp Pathol; 2011; 144(2-3):170-9. PubMed ID: 20880546
[TBL] [Abstract][Full Text] [Related]
33. The expression of p63 and cytokeratin 5 in mixed tumors of the canine mammary gland provides new insights into the histogenesis of these neoplasms.
Ramalho LN; Ribeiro-Silva A; Cassali GD; Zucoloto S
Vet Pathol; 2006 Jul; 43(4):424-9. PubMed ID: 16846983
[TBL] [Abstract][Full Text] [Related]
34. Expression of Cox-1 and Cox-2 in canine mammary tumours.
Queiroga FL; Alves A; Pires I; Lopes C
J Comp Pathol; 2007; 136(2-3):177-85. PubMed ID: 17416236
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical detection of progesterone and cellular proliferation in canine mammary tumours.
Thuróczy J; Reisvaag GJ; Perge E; Tibold A; Szilágyi J; Balogh L
J Comp Pathol; 2007; 137(2-3):122-9. PubMed ID: 17645888
[TBL] [Abstract][Full Text] [Related]
36. Mucin 6 and Tn antigen expression in canine mammary tumours: correlation with pathological features.
Tavares C; de Oliveira JT; Lopes C; Carvalheira J; Matos AJ; Rutteman G; Reis CA; Gärtner F
J Comp Pathol; 2012 Nov; 147(4):410-8. PubMed ID: 22595635
[TBL] [Abstract][Full Text] [Related]
37. Erythropoietin receptor expression in canine mammary tumor: an immunohistochemical study.
Sfacteria A; Mazzullo G; Bertani C; Calabrò P; De Vico G; Macrì B
Vet Pathol; 2005 Nov; 42(6):837-40. PubMed ID: 16301583
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical detection of p53 tumor suppressor gene protein in canine epithelial colorectal tumors.
Wolf JC; Ginn PE; Homer B; Fox LE; Kurzman ID
Vet Pathol; 1997 Sep; 34(5):394-404. PubMed ID: 9381650
[TBL] [Abstract][Full Text] [Related]
39. Expression and prognostic significance of CK19 in canine malignant mammary tumours.
Gama A; Alves A; Schmitt F
Vet J; 2010 Apr; 184(1):45-51. PubMed ID: 19264518
[TBL] [Abstract][Full Text] [Related]
40. E-cadherin expression in canine malignant mammary tumours: relationship to other clinico-pathological variables.
Matos AJ; Lopes C; Carvalheira J; Santos M; Rutteman GR; Gärtner F
J Comp Pathol; 2006; 134(2-3):182-9. PubMed ID: 16545841
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
